Trial
NCT00004465
Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborators
Long Island Jewish Medical Center
Condition
Hemolytic Uremic Syndrome
Intervention
SYNSORB Pk
Why stopped
Lack of efficacy at review by DSMB using pre-specified monitoring criteria
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-01